145 related articles for article (PubMed ID: 29143198)
1. The effect of parental age on NF1 patients in Turkey.
Sharafi P; Anlar B; Ersoy-Evans S; Varan A; Yılmaz OF; Turan M; Ayter S
J Community Genet; 2018 Jul; 9(3):227-232. PubMed ID: 29143198
[TBL] [Abstract][Full Text] [Related]
2. The effect of parental age on the presence of de novo mutations - Lessons from neurofibromatosis type I.
Dubov T; Toledano-Alhadef H; Bokstein F; Constantini S; Ben-Shachar S
Mol Genet Genomic Med; 2016 Jul; 4(4):480-6. PubMed ID: 27468422
[TBL] [Abstract][Full Text] [Related]
3. The importance of advanced parental age in the origin of neurofibromatosis type 1.
Snajderova M; Riccardi VM; Petrak B; Zemkova D; Zapletalova J; Mardesic T; Petrakova A; Lanska V; Marikova T; Bendova S; Havlovicova M; Kaluzova M
Am J Med Genet A; 2012 Mar; 158A(3):519-23. PubMed ID: 22302476
[TBL] [Abstract][Full Text] [Related]
4. Paternal age and sporadic neurofibromatosis 1: a case-control study and consideration of the methodologic issues.
Bunin GR; Needle M; Riccardi VM
Genet Epidemiol; 1997; 14(5):507-16. PubMed ID: 9358268
[TBL] [Abstract][Full Text] [Related]
5. Parental age and Neurofibromatosis Type 1: a report from the NF1 Patient Registry Initiative.
Liu Q; Zoellner N; Gutmann DH; Johnson KJ
Fam Cancer; 2015 Jun; 14(2):317-24. PubMed ID: 25523354
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients.
Lázaro C; Gaona A; Ainsworth P; Tenconi R; Vidaud D; Kruyer H; Ars E; Volpini V; Estivill X
Hum Genet; 1996 Dec; 98(6):696-9. PubMed ID: 8931703
[TBL] [Abstract][Full Text] [Related]
7. Mutations in von Recklinghausen neurofibromatosis: an hypothesis.
Zlotogora J
Am J Med Genet; 1993 Apr; 46(2):182-4. PubMed ID: 8484407
[TBL] [Abstract][Full Text] [Related]
8. Evidence of advanced parental age linked to sporadic schizophrenia.
Kollias C; Dimitrakopoulos S; Xenaki LA; Stefanis N; Papageorgiou C
Psychiatriki; 2019; 30(1):24-31. PubMed ID: 31115351
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type 1 in two siblings due to maternal germline mosaicism.
Trevisson E; Forzan M; Salviati L; Clementi M
Clin Genet; 2014 Apr; 85(4):386-9. PubMed ID: 23621909
[TBL] [Abstract][Full Text] [Related]
10. Possible modifier genes in the variation of neurofibromatosis type 1 clinical phenotypes.
Sharafi P; Ayter S
J Neurogenet; 2018; 32(2):65-77. PubMed ID: 29644913
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene.
Richards FM; Payne SJ; Zbar B; Affara NA; Ferguson-Smith MA; Maher ER
Hum Mol Genet; 1995 Nov; 4(11):2139-43. PubMed ID: 8589692
[TBL] [Abstract][Full Text] [Related]
12. Paternal age and sporadic schizophrenia: evidence for de novo mutations.
Malaspina D; Corcoran C; Fahim C; Berman A; Harkavy-Friedman J; Yale S; Goetz D; Goetz R; Harlap S; Gorman J
Am J Med Genet; 2002 Apr; 114(3):299-303. PubMed ID: 11920852
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
[TBL] [Abstract][Full Text] [Related]
14. Early-Onset Breast Cancer in a Family with Neurofibromatosis Type 1 Associated with a Germline Mutation in BRCA1.
Jeon YW; Kim RM; Lim ST; Choi HJ; Suh YJ
J Breast Cancer; 2015 Mar; 18(1):97-100. PubMed ID: 25834617
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of sporadic and inherited mutations in exon 31 of the neurofibromatosis (NF1) gene.
Ainsworth PJ; Rodenhiser DI; Costa MT
Hum Genet; 1993 Mar; 91(2):151-6. PubMed ID: 8385067
[TBL] [Abstract][Full Text] [Related]
16. [Anxiety disorders in type 1 neurofibromatosis: A case report].
Fekih-Romdhane F; Othman S; Sahnoun C; Helayem S; Abbes Z; Bouden A
Arch Pediatr; 2015 Sep; 22(9):956-60. PubMed ID: 26228808
[TBL] [Abstract][Full Text] [Related]
17. Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients.
Kayes LM; Burke W; Riccardi VM; Bennett R; Ehrlich P; Rubenstein A; Stephens K
Am J Hum Genet; 1994 Mar; 54(3):424-36. PubMed ID: 8116612
[TBL] [Abstract][Full Text] [Related]
18. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
19. [Neurofibromatosis: the most frequent hereditary tumor predisposition syndrome].
Wimmer K
Wien Med Wochenschr; 2005 Jun; 155(11-12):273-80. PubMed ID: 16035388
[TBL] [Abstract][Full Text] [Related]
20. [Mutagenic effect of advanced paternal age in neurocardiofaciocutaneous syndrome].
Seemanová E; Zenker M
Cas Lek Cesk; 2014; 153(5):242-5. PubMed ID: 25370770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
